264 related articles for article (PubMed ID: 781380)
1. Classical complement pathway activation in membranoproliferative glomerulonephritis.
Ooi YM; Vallota EH; West CD
Kidney Int; 1976 Jan; 9(1):46-53. PubMed ID: 781380
[TBL] [Abstract][Full Text] [Related]
2. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
[TBL] [Abstract][Full Text] [Related]
3. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
Lévy M; Sich M; Habib R
Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
[TBL] [Abstract][Full Text] [Related]
4. Patterns of complement activation in idiopathic membranoproliferative glomerulonephritis, types I, II, and III.
Varade WS; Forristal J; West CD
Am J Kidney Dis; 1990 Sep; 16(3):196-206. PubMed ID: 2205097
[TBL] [Abstract][Full Text] [Related]
5. Immunofluorescence patterns in chronic membranoproliferative glomerulonephritis (MPGN).
Belgiojoso GB; Tarantino A; Bazzi C; Colasanti G; Guerra L; Durante A
Clin Nephrol; 1976 Jul; 6(1):303-10. PubMed ID: 782750
[TBL] [Abstract][Full Text] [Related]
6. Immunopathology of membranoproliferative glomerulonephritis with subendothelial deposits (Type I MPGN).
Levy M; Gubler MC; Sich M; Beziau A; Habib R
Clin Immunol Immunopathol; 1978 Aug; 10(4):477-92. PubMed ID: 357058
[No Abstract] [Full Text] [Related]
7. Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.
Donadelli R; Pulieri P; Piras R; Iatropoulos P; Valoti E; Benigni A; Remuzzi G; Noris M
Front Immunol; 2018; 9():2329. PubMed ID: 30487789
[TBL] [Abstract][Full Text] [Related]
8. Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings.
Kim Y; Vernier RL; Fish AJ; Michael AF
Lab Invest; 1979 Apr; 40(4):474-80. PubMed ID: 372673
[TBL] [Abstract][Full Text] [Related]
9. A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III.
Clardy CW; Forristal J; Strife CF; West CD
Clin Immunol Immunopathol; 1989 Mar; 50(3):333-47. PubMed ID: 2917424
[TBL] [Abstract][Full Text] [Related]
10. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
Habib R; Lévy M; Gubler MC; Broyer M; Habib M
Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
[TBL] [Abstract][Full Text] [Related]
11. Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane.
Strife CF; McEnery PT; McAdams AJ; West CD
Clin Nephrol; 1977 Feb; 7(2):65-72. PubMed ID: 844227
[TBL] [Abstract][Full Text] [Related]
12. Discordant renal histopathologic findings and complement profiles in membranoproliferative glomerulonephritis type III.
Meyers KE; Strife CF; Witzleben C; Kaplan BS
Am J Kidney Dis; 1996 Dec; 28(6):804-10. PubMed ID: 8957031
[TBL] [Abstract][Full Text] [Related]
13. Alternative C3 pathway activiation in pneumococcal glomerulonephritis.
Hyman LR; Jenis EH; Hill GS; Zimmerman SW; Burkholder PM
Am J Med; 1975 Jun; 58(6):810-4. PubMed ID: 1094828
[TBL] [Abstract][Full Text] [Related]
14. Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.
Davis BK; Cavallo T
Am J Pathol; 1976 Aug; 84(2):283-98. PubMed ID: 133617
[TBL] [Abstract][Full Text] [Related]
15. Measles and acute glomerulonephritis.
Lin CY; Hsu HC
Pediatrics; 1983 Mar; 71(3):398-401. PubMed ID: 6219335
[TBL] [Abstract][Full Text] [Related]
16. [Complement system in glomerulonephritis. II. Detailed aspects].
Bodalski J; Narebska E; Jerzmanowski A
Pediatr Pol; 1980 Jun; 55(6):805-11. PubMed ID: 7413331
[No Abstract] [Full Text] [Related]
17. Two types of C3 nephritic factor: properdin-dependent C3NeF and properdin-independent C3NeF.
Tanuma Y; Ohi H; Hatano M
Clin Immunol Immunopathol; 1990 Aug; 56(2):226-38. PubMed ID: 2143128
[TBL] [Abstract][Full Text] [Related]
18. [Transitory deficiency of Clq and C4 in a case of chronic glomerulonephritis].
Schena FP; Piscitelli M; Lucivero G; Marzullo F
Minerva Nefrol; 1975; 22(6):266-71. PubMed ID: 1223704
[No Abstract] [Full Text] [Related]
19. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
[TBL] [Abstract][Full Text] [Related]
20. [Activation of the complement system in different forms of glomerulonephritis].
Wegmüller E; Frey B; Hodler J
Schweiz Med Wochenschr; 1977 Jul; 107(29):1028-34. PubMed ID: 331469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
